Unicycive Therapeutics, Inc. (UNCY)
NASDAQ: UNCY · Real-Time Price · USD
0.5979
+0.0230 (4.00%)
Apr 1, 2025, 9:42 AM EDT - Market open

Unicycive Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2018
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2018
Net Income
-36.73-30.54-18.06-10.02-2.26
Upgrade
Depreciation & Amortization
0.430.280.160.01-
Upgrade
Other Amortization
---0.490.19
Upgrade
Asset Writedown & Restructuring Costs
---2.190.1
Upgrade
Stock-Based Compensation
2.351.771.051.110.63
Upgrade
Other Operating Activities
5.810.30.020.550.05
Upgrade
Change in Accounts Payable
0.791.281.271.24-0.07
Upgrade
Change in Other Net Operating Assets
-1.22-1.37-0.09-1.35-0.1
Upgrade
Operating Cash Flow
-28.58-18.28-15.65-5.77-1.46
Upgrade
Capital Expenditures
-0.07-0.01-0-0.03-
Upgrade
Investing Cash Flow
-0.07-0.01-0-0.03-
Upgrade
Short-Term Debt Issued
---1.351.58
Upgrade
Total Debt Issued
---1.351.58
Upgrade
Short-Term Debt Repaid
----1.36-0.16
Upgrade
Total Debt Repaid
----1.36-0.16
Upgrade
Net Debt Issued (Repaid)
----0.021.42
Upgrade
Issuance of Common Stock
0.68-0.0122.390.14
Upgrade
Common Dividends Paid
-1.1----
Upgrade
Other Financing Activities
-4.5-2.65-0.48--0.12
Upgrade
Financing Cash Flow
45.0927.54-0.4722.381.44
Upgrade
Net Cash Flow
16.449.25-16.1216.58-0.02
Upgrade
Free Cash Flow
-28.65-18.3-15.65-5.8-1.46
Upgrade
Free Cash Flow Margin
--2710.37%-1645.95%--
Upgrade
Free Cash Flow Per Share
-0.43-0.75-1.04-0.50-0.17
Upgrade
Cash Interest Paid
-0.020.01--
Upgrade
Cash Income Tax Paid
----0
Upgrade
Levered Free Cash Flow
-14.521.57-9.26-4.6-1.28
Upgrade
Unlevered Free Cash Flow
-14.481.62-9.26-4.7-1.31
Upgrade
Change in Net Working Capital
-5.24-12.57-0.820.040.28
Upgrade
Updated Nov 13, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q